American medics and hospitals providing sex-swap drugs and surgeries for children have the support of the “highest levels of the Federal Government”, a senior official has said.
The Assistant Secretary of Health and Human Services, Rachel Levine, a man who lives as a woman, said “proactive outreach” is needed to “educate the public” that any opposition to ‘gender-affirming care’ is “ideologically and politically motivated”.
He told staff at Connecticut Children’s Hospital to “push back” in their communities and schools when ‘gender-affirming care’ is questioned.
‘Dubious studies’
Levine has previously criticised a law in Florida requiring teachers to inform parents when their children question their gender.
“Treatment for minors needs to be based on rigorous scientific inquiry, not on dubious, agenda-driven studies or the demands of activists.”
Dr Stanley Goldfarb, Chairman of Do No Harm, a network of medical professionals, said: “There is no good evidence that children treated with gender-altering hormones or puberty blockers have improved mental health assessments.”
“There can be irrevocable harm being done to children by those pushing for these radical, ideologically driven, treatments.
“Treatment for minors needs to be based on rigorous scientific inquiry, not on dubious, agenda-driven studies or the demands of activists.”
‘Reprehensible’
Member of the House Doctors Caucus, Andy Harris, called it “reprehensible for a government official, let alone the Assistant U.S. Secretary of HHS to promote the genital mutilation of minors as becoming a standard practice in the U.S.”.
He said: “Many paediatricians, particularly pediatric endocrinologists, have expressed serious concerns about the use of puberty blockers, hormone blockers, and sex transition surgeries in minors.
“These doctors know that these medications and procedures can impact children’s bone growth, fertility, and risk of breast and prostate cancer.”
Systematic review
Last year, paediatricians in the US challenged the American Academy of Pediatrics (AAP) over its ‘affirming’ approach to transgenderism.
The medics called for a rigorous and systematic review of the evidence and its guidelines on gender dysphoria, but the formal resolution was blocked.
Dr Julia Mason, an advisor for the Society of Evidence-based Gender Medicine and one of the authors of the resolution, told the Daily Mail that more and more colleagues want to “slow down” the mass handout of puberty-blocking drugs to gender-confused children.
Dr Quentin Van Meter, President of the American College of Pediatricians called the AAP’s current guidelines “the opinions of ideologues, not scientist physicians or members”.
Calls for caution
In recent years, the evident lack of research on adolescent onset gender dysphoria led to reviews of national programmes by health officials in Finland, Sweden and the United Kingdom.
According to Finland’s leading transgender expert, there is overwhelming evidence for the link between exposure to social media and the desire for gender transitions among female teenagers.
She also said ‘gender-affirming treatments’ administered in the US, including social transition, were likely to solidify patients’ problems instead of treating them.
Tavistock exposé: ‘A definitive record of what happened’
US paediatricians want ‘evidence not ideology’ for gender-confused kids
